Merrimack Pharmaceuticals Inc (MACK)
14.72
0.00 (0.00%)
USD |
NASDAQ |
Apr 23, 16:00
14.72
0.00 (0.00%)
After-Hours: 20:00
Merrimack Pharmaceuticals Cash from Investing (Quarterly): 0.068M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.068M |
| September 30, 2023 | -3.845M |
| June 30, 2023 | -8.811M |
| March 31, 2023 | 0.139M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.445M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.094M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.05M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -0.311M |
| March 31, 2020 | 2.45M |
| December 31, 2019 | 5.00M |
| September 30, 2019 | 6.50M |
| June 30, 2019 | 28.21M |
| March 31, 2019 | 30.12M |
| December 31, 2018 | -10.82M |
| September 30, 2018 | 25.62M |
| June 30, 2018 | 4.435M |
| March 31, 2018 | -41.83M |
| December 31, 2017 | 5.528M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.454M |
| June 30, 2017 | 576.11M |
| March 31, 2017 | -0.29M |
| December 31, 2016 | 11.71M |
| September 30, 2016 | 48.34M |
| June 30, 2016 | 22.18M |
| March 31, 2016 | -85.49M |
| December 31, 2015 | 1.338M |
| September 30, 2015 | 23.91M |
| June 30, 2015 | 25.90M |
| March 31, 2015 | 23.96M |
| December 31, 2014 | -37.10M |
| September 30, 2014 | -40.56M |
| June 30, 2014 | 40.59M |
| March 31, 2014 | 31.06M |
| December 31, 2013 | -14.06M |
| September 30, 2013 | -51.05M |
| June 30, 2013 | 25.87M |
| March 31, 2013 | 11.51M |
| December 31, 2012 | -15.37M |
| September 30, 2012 | 14.97M |
| June 30, 2012 | -74.39M |
| March 31, 2012 | -0.426M |
| December 31, 2011 | -1.287M |
| September 30, 2011 | -0.628M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-8.811M
Minimum
Jun 2023
28.21M
Maximum
Jun 2019
1.578M
Average
--
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 9.462M |
| iBio Inc | 0.00 |
| Theriva Biologics Inc | -0.056M |
| Oragenics Inc | -1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.295M |
| Cash from Financing (Quarterly) | 0.133M |
| Free Cash Flow | -1.522M |
| Free Cash Flow Per Share (Quarterly) | -0.0206 |
| Free Cash Flow Yield | -0.72% |